NZ Launches Onshore Genomic Trial for Cancer and Rare Disorders
New Zealand has initiated a landmark genomic trial designed to bring advanced diagnostic testing onshore for patients with cancer and rare disorders. The program aims to reduce the 'diagnostic odyssey' by eliminating the need to send biological samples to overseas laboratories.